title: [Results of rotational gamma teletherapy of prostatic cancer].
abstract: Remote rotational gamma-therapy was carried out in 36 cases of prostatic cancer. Hormonal treatment was given to 27 patients before gamma-therapy. There was a 2-4 week interval in the course of treatment. Single focal dose was 2 Gy and total dose--56-71 Gy. Complete resorption of tumor was in 26 and reduction in tumor size in 9 patients. Recurrences were registered in 9 out of 26 cases within the first two years after exposure termination. Bone metastases were observed in 7 out of 36 cases within 9-48 months after treatment. Hormones were administered to patients with metastases as well as cases of incomplete cure and recurrences. The patients were followed up during periods ranging from 6 months to 7 years. Survival for more than 3 years was recorded in 61% of cases. No radiation injury was observed. Rotational remote gamma-therapy may be used for treatment of local prostatic cancer.
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000556:secondary; D005720:Gamma Rays / Q000627:therapeutic use; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010347:Patient Care Planning; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011879:Radiotherapy Dosage
vernacular_title: Rezul'taty rotasionnoĭ distantsionnoĭ gamma-terapii raka predstatel'noĭ zhelezy.